References
- Goodrich D.W., Wang N.P., Qian Y.W., Lee E. Y. H. P., Lee W.H. The retinoblastoma gene product regulates progression through the Gl phase of the cell cycle. Cell 1991; 67: 293–302
- Dyson N., Howley P.M., Miinger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934–937
- Whyte P., Buchkovich K.J., Horowitz J.M., Friend S., Raybuck M., Weinberg R., Harlow E. Association between an oncogene and an antioncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124–129
- De Caprio J.A., Ludlow J.W., Figge J., Shew J.Y., Huang C.M., Lee W.H., Marsilio E., Paucha E., Livingstone D.M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–283
- Shirodkar S., Ewen M., De Caprio J.A., Morgan J., Livingstone D.M., Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle regulated manner. Cell 1992; 68: 157–166
- Dunn I.M., Phillips R.A., Becker A.J., Gallie B.L. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988; 241: 1797–1800
- Benedict W.F., Fung Y. K. T., Murphree A.L. The gene responsible for the development of retinoblastoma and osteosarcoma. Cancer 1988; 62: 1691–1694
- Harbour J.W., Lai S.L., Whang-Peng J., Gazdar A.F., Minna J.D., Kaye F.J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241: 353–357
- Horowitz J.M., Park S.H., Bogenmann E., Cheng J.C., Yandell D.W., Kaye F.J., Minna I.D., Dryja T.P., Weinberg R.A. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 1990; 87: 2775–2779
- Bookstein R., Shew J.Y., Chen P.L., Scully P., Lee W.H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990; 247: 712–715
- Weide R., Tiemann M., Pfluger K.H., Köppler H., Parviz B., Wacker H.H., Kreipe H.H., Havemann K., Parwaresch M.R. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia 1994; 8: 97–101
- Weide R., Parviz B., Pfluger K.H., Havemann K. Altered expression of the human retinoblastoma gene in monocytic leukaemias. Brit. J. Haematol. 1993; 83: 428–432
- Ahuja H.G., Jat P.S., Foti A., Bar-Eli M., Cline M.J. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemias. Blood 1991; 78: 3259–3268
- Tang J.L., Yeh S.H., Chen P.J., Lin M.T., Tien H.F., Chen Y.C. Inactivation of the retinoblastoma gene in acute myelogenous leukaemia. Brit. J. Haematol. 1992; 82: 502–507
- Kornblau S.M., Xu H.J., Giglio A., Hu S.X., Zhang W., Calvert L., Beran M., Estey E., Andreef M., TrujilIo J., Cork M.A., Smith T.L., Benedict W.F., Deisseroth A.B. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res. 1992; 52: 4587–4590
- Pegoraro L., Matera L., Ritz J., Levis A., Palumbo A., Biagini G. Establishment of a Ph-chromosome positive human cell line (BV173). J. Natl. Cancer Inst. 1983; 70: 447–451
- Fahey J.L., Buell D.N., Sox H.C. Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann. N. Y. Acad. Sci. 1972; 190: 221–234